期刊文献+

社区护理干预对改善绝经后妇女骨质疏松症的效果观察 被引量:4

原文传递
导出
摘要 选取我中心辖区内90例绝经后骨质疏松症患者,随机分为社区护理干预组(43例)和对照组(47例)。干预组按医嘱每天口服钙剂600 mg、维生素D 800 U,阿仑膦酸钠70 mg每周口服1次。采用系统的社区护理干预,如健康宣教,饮食、运动、服药指导等,干预时间为1年。干预组实施社区护理干预措施后,患者的乏力、腰酸背痛、骨痛等好转或消失。干预组患者疾病知识知晓率、护理依从性、骨密度提高率均明显高于对照组,骨折发生率明显低于对照组(P<0.05)。说明系统的护理干预对改善绝经后的骨质疏松症有效,对减轻患者痛苦和提高生活质量意义重大。
作者 赖春晖
出处 《社区医学杂志》 2012年第10期72-73,共2页 Journal Of Community Medicine
  • 相关文献

参考文献4

二级参考文献50

  • 1林华.骨质疏松的评估——骨量与骨质量[J].中国医刊,2004,39(6):2-4. 被引量:16
  • 2彭绩,梁渊,卢祖洵.骨质疏松症危险因素的Meta分析[J].中国公共卫生,2004,20(5):585-586. 被引量:38
  • 3季颖,阮祥燕,刘忠厚.老年人跌倒的预防[J].中国骨质疏松杂志,2004,10(3):380-383. 被引量:40
  • 4刘健,蔡太生.骨质疏松症生活质量量表理论结构的因素分析[J].中国行为医学科学,2005,14(11):1048-1048. 被引量:4
  • 5[1]Writing group for the women's health investigators.Risk and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the women's health initative bandomized controlled trial.JAMA,2002,288:321-323.
  • 6[2]The IMS executive committee.Guidelines for hormone treatment of women in the menopausal transition and beyond.Maturitas,2005,51(1):15-20.
  • 7中华人民共和国卫生部医政司.中国康复医学诊疗规范[M].北京:华夏出版社,1999.129.
  • 8Brown JP,Josse RG.2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada[J].Can Med Assoc J,2002,167:1-34.
  • 9Cummings SR,Karpf DB,Harris F,et al.Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs[J].Am J Med,2002,112(4):281-289.
  • 10Joel A.Delisa等著,南登昆等译.康复医学-理论与实践[M].第3版.西安:世界图书出版公司,2004.

共引文献33

同被引文献68

  • 1黄丽红.原发性骨质疏松症的社区护理干预初探[J].当代护士(中旬刊),2006,13(7):91-92. 被引量:4
  • 2陈玉平,刘雪琴,蔡德鸿.对社区中老年人骨质疏松症的健康教育效果评价[J].护理研究(上旬版),2006,20(3):650-652. 被引量:22
  • 3赵月仙.社区护理干预对减轻老年骨质疏松病人疼痛的作用[J].护理研究(上旬版),2006,20(5):1213-1214. 被引量:11
  • 4鄢凤仙.社区护理干预对老年骨质疏松症患者的影响[J].护理学报,2006,13(5):64-65. 被引量:13
  • 5肖菊梅.朱小忠,韩晓华.护理宣教干预对绝经后妇女骨质疏松的影响.中国优生优育,2014,20(3):185-186.
  • 6Okumus M, Ceceli E,Tasbas O, et al. Educational status and knowledge level of pre-and postmenopausal women about osteoporosis and risk factors:a cross-sectional study in a group of Turkish female subjects [J]. J Back Muscu-loskelet Rehabil, 2013,26 (3) : 337-343.
  • 7Navarro Mdel C,Saavedra P,G6mez-de-Tejada MJ,et al. Discriminative ability of heel quantitative ultrasound in postmenopausal women with prevalent vertebral frac- tures: application of optimal threshold cutoff values us- ing classification and regression tree models [J]. Calcif Tissue Int,2012,91(2) : 114-120.
  • 8Palacios S, Neyro JL, Puertas JC, et al. Clinical profile of Spanish postmenopausal women with a diagnosis of os- teoporosis and risk factors for endometrial pathology, breast cancer, and cardiovascular disease [J]. Menopause, 2013,20(8) :852-859.
  • 9Goldberg T,Fidler B. Conjugated Estrogens/Bazedoxifene (Duavee):a novel agent for the treatment of moderate- to-severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis [J]. P T, 2015,40(3) : 178-182.
  • 10WHO Study Group. Assessment of fracture risk gind its applica lion to screening for poslmenopausal osteoporosis. 1901 WHOtechnical Report Series NO. 843[R]. Geneva~WHO, 1994 : 1.

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部